KLK3 and Patent ductus arteriosus: Consequently, patients with this subtype are 2.4 times more prone to exhibit PSA levels below 4.0 ng/ml compared to those with AA, with a substantial proportion of PDA patients registering PSA levels below this threshold upon diagnosis (17).